DNER and cancer: BY27 is a compound that selectively inhibits BD2 and demonstrates promising anticancer properties.143 It has been found to effectively inhibit cancer growth in mice while exhibiting lower toxicity compared to pan-BET inhibitors.143 The unique structural features of BY27 make it a promising candidate for the development and synthesizing of future BD2 selective inhibitors.143